Therefore, synthetic lethality, or more specifically synthetic dosage lethality, can be advantageous in cancer as the tumors already have mutations or oncogenic addiction, such as overexpression of MYC. A synthetic lethal approach affects the mutated tumor cells and spares the normal cells. The gene discussed is MYC; the disease is neoplasm.